Plain-English translation of NCT02960022 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is an extension study for men with prostate cancer who were already taking in an earlier clinical trial and want to keep taking it. The study lets you continue the same treatment you were receiving—which may be alone, or combined with other medications—as long as your doctor believes you are still benefiting from it. Researchers will monitor you regularly to track how the medication is working and watch for any side effects.
Once a clinical trial ends, patients who are doing well on the medication often want to keep taking it rather than stop. This trial exists to give those patients a way to continue their treatment safely while doctors keep track of their health and gather more information about how well the medication works over time.
You will continue taking the same medication you were taking in your previous study, at the same dose, once daily. You'll visit your doctor every 24 weeks (about 6 months) to check in about how you're doing, review any side effects, and pick up more medication if needed. Every 12 weeks, you'll also have a brief visit just to pick up your next supply. Your doctor will follow standard care practices and watch for any new health concerns throughout the study.
AI-generated summary from trial data · Sep 11, 2026 · Not medical advice
United States